The definitions of 'health claim' and 'reduction of disease risk claim' should be interpreted broadly.

A string of successful prosecutions by the Food Authority should alert businesses to comply with food safety obligations.

The Court lifted an injunction restraining the supply of GSK's Panadol which incorporated a liquid dispensing apparatus.

Reforms include proposed changes to innovation patents and a review of current arrangements for pharmaceutical patents.

The NSW Government proposes to implement a new program, which would give some drug offenders a second chance.

The Redfern Legal Centre appealed that NSW Police release its full drug dog SOPs, so that the public was better informed

In New South Wales, it is an offence to possess any item of equipment for use in the administration of a prohibited drug.

Despite numerous drug-related deaths and two successful trials, pill testing remains illegal in Australia.

Law enforcement agencies typically use police dogs and sniffer dogs to detect drugs.

The addition of cocaine brings Qld roadside drug tests in line with NSW – where cocaine has been part of MDT since 2018.

This bill provides patients who use medical cannabis with a defence for driving with traces of THC in their system.

Festivalgoers escaping the so-called emergency situation were pulled over to be breathalysed and drug tested by police.

This is an overview of the clinical trial landscape and its risks, showing how the events in France could lead to change.

Outlines your rights at music festivals.

Recent legislative reforms change the classification and the advertising requirements in respect of therapeutic goods.

Products which are also regulated include certain sunscreens, acne treatments, soaps, anti-perspirants and hair products.

New laws relating to the sale of alkyl nitrite products – also known as 'poppers' – come into effect on 1 February 2020.

The differences seem to be from matters of expert evidence more than major variations in application of legal principle.

The Evolva and MacroGenics decisions provide some guidance on how the Australian Patent Office could assess plausibility.

The Court found Pfizer's strategies were legitimate forms of competition in the face of sustained attack by generics.